Research
Featured Article: Curcumin: the spicy modulator of breast carcinogenesis
Despite best efforts, a cure for breast cancer remains yet to be discovered. However, advances in treatment and prevention are making great progress in breast cancer research. Over the years, naturally-sourced products are becoming increasingly popular in breast cancer therapy and prevention. Curcumin is the main component of turmeric, a spice derived from the ginger plant family. Historically, curcumin has been used as a homemade remedy for a variety of medical complaints, however in recent years, the role of curcumin as a promising natural anticancer agent has been of particular interest.
In this review, U Banik et al., highlight the effects that curcumin can have on breast carcinogenesis and discuss the potential for this natural product to play a major role in breast cancer research.
Click here to access the full article.
Click here to access all of the reviews published to date in JECCR.
Articles
-
-
Research
PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a
Published on: 15 September 2017
-
Review
Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research
Published on: 13 September 2017
-
Research
-
Research
ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population
Published on: 11 September 2017
Aims and scope
JECCR is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and translational work in oncology.
Manuscript turnaround times
Following rigorous peer review of a manuscript, authors can expect to receive a first decision within 30 days.
Commentaries
JECCR now welcomes submissions of commentaries that either discuss recently published research or covers an aspect of a issue relevant to the journal's scope.
Archival content
JECCR has been publishing since 1982. Prior to 2008, JECCR was published in print. For enquiries about previous content, please contact us.
Advertisement
